Latest filing published 05 Mar 2026 for Monte Rosa Therapeutics, Inc., €2,150.
Filing timeline
BuySaleInsider track record
Edmund Dunn: trading record in brief
This profile gathers the share dealings of Edmund Dunn in Monte Rosa Therapeutics, Inc. We count 10 filings; the first trade dates from 3 June 2024 and the latest from 4 March 2026.
Sales make up the whole of the open-market record (7 sales, €428k). The rest of the record consists of 1 share grant and 2 option exercises. In 2026 alone, the filings show no purchases and 4 sales.
On 5 March 2026 came the latest disclosure, an open-market sale for €2,150 in Monte Rosa Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Edmund Dunn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 139 shares@ US$17.960.7% of flowCommon StockSEC:0001193125-26-094296:0
- 25,164 shares@ US$13.4189.4% of flowCommon StockSEC:0001193125-26-085677:0
- 1,039 shares@ US$15.174.2% of flowCommon StockSEC:0001193125-26-002390:0
- 2,062 shares@ US$4.44932.5% of flowCommon StockSEC:0000950170-25-081637:0
- 11,850 sharesCommon StockSEC:0000950170-25-002103:0
- 1,610 shares@ US$3.83011.8% of flowCommon StockSEC:0000950170-24-082416:0
- 1,207 shares@ US$4.03961.4% of flowCommon StockSEC:0000950170-24-069310:0
7 of 7 declarations
